newsfilter
← Latest News
Business Wire·

DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights

Conference Call and Webcast May 14 at 8:00 AM Eastern Time / 7:00 AM Central Time Topline DM199 Preeclampsia Phase 2 Part 1A Proof of Concept Results Expected in Near Term and Phase 2 Part 1B Expected to Initiate in